| abstract |
The present invention relates to a composition consisting of or containing peptides selected from the group consisting of or containing rd2, d3, homologues of at least 50% identity and derivatives of rd2 or d3, as well as polymers, contain or consist of rd2-d3 homologs with an identity of at least 50% and rd2 and d3 derivatives for use as an analgesic, for use in pain therapy, for use in the treatment of chronic and / or neuropathic pain and / or to inhibit n-type neuronal calcium channels (ncc). |